SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant market volatility after a Blue Origin launch failed to place the BlueBird 7 satellite into its intended orbit. While the company maintains that insurance will cover the loss and that their broader deployment roadmap remains intact, the community is actively debating whether this represents an isolated technical setback or a sign of deeper risks regarding launch provider reliability and execution timelines.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as a high-conviction AI infrastructure play, fueled by a potential custom chip partnership with Google and sustained momentum from the semiconductor sector's recovery. Community discussion remains focused on its role as a backbone for AI inference and data center growth, with traders closely monitoring its technical breakout and institutional volume.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Compass Pathways is trending as market sentiment strengthens following recent clinical progress and anticipation of pending Phase 3 data releases, fueling speculation about the company's path to potential FDA approval. Investors are actively discussing the firm's competitive position within the psychedelic-assisted therapy sector and its overall capital runway, with community focus zeroing in on key upcoming regulatory milestones.

AEVEX Corp. operates as a holding company. It operates through Tactical Systems and Global Solutions segments. The Tactical Systems segment focuses on design, development, and production of autonomous systems including unmanned aerial systems and unmanned surface vessels. The Global Solutions segment offers services and mission support to defense and intelligence customers. The company was founded in 2017 and is headquartered in Solana Beach, CA.

AEVEX Corp. - Ordinary Shares - Class A

AEVEX Corp. is trending following its recent IPO debut, as market participants flock to the drone manufacturer for its exposure to the defense sector and government contracts. Community discussion is heavily focused on the stock's potential for momentum-driven gains, with traders actively debating its valuation compared to peers and monitoring for high-volatility moves amid broader geopolitical concerns.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently the center of active community debate, with investors heavily focused on its strategic partnerships with industry giants like NVIDIA and its unique neutral-atom quantum technology. Traders are keenly watching for potential price action spikes and analyzing the impact of share lock-up expirations, while many believe the stock's valuation has significant room to run compared to other quantum sector peers.

Mika, an AI waifu powered by Chasm. (with rizz)  No more lonely nights as she'll be with you through Telegram and more.  No more diddy parties, $GMIKA by Mika is all you need.  Let Mika cook.

New World Order

The ticker is trending amid intense community speculation regarding geopolitical instability, potential impacts of energy sector policies, and ongoing debates over market volatility. Traders are closely monitoring these developments alongside technical support and resistance levels to navigate the uncertainty.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is generating intense community interest driven by a presidential executive order aimed at fast-tracking FDA reviews and research funding for psychedelics like ibogaine. Traders are debating a potential short squeeze, highlighting the company's thin float and GMP-compliant ibogaine supply chain as key catalysts while others warn of volatility and event-driven speculation.

Roundhill ETF Trust - Roundhill Memory ETF

The DRAM ETF is attracting investor attention as a streamlined way to gain exposure to the global memory oligopoly, specifically capitalizing on the structural shift toward AI-driven demand for HBM and NAND. Community sentiment remains largely bullish, focusing on the potential for industry re-rating, though some investors are debating the risks associated with the fund's recent launch and its liquidity dynamics.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing a surge in activity as investors react to a White House executive order aimed at accelerating psychedelic research, which has sparked optimism regarding potential National Priority Vouchers. The community is intensely debating the stock's future, balancing enthusiasm over favorable policy tailwinds against persistent concerns surrounding past leadership controversies, share dilution, and the company's long-term commercial viability.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to the anticipation surrounding upcoming AACR conference presentations, where the company and its steering committee are expected to unveil statistically significant immune response data and updated efficacy findings from the FLAMINGO-01 Phase III trial. Community members are actively debating the significance of recent trial protocol modifications, potential M&A scenarios, and the company's manufacturing progress, with many remaining bullish on the stock's long-term potential as they wait for the 14-event interim analysis.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM PR Newswire NEW YORK, April 16, 2026 NEW YORK, April 16, 2026...

Journey Medical Corporation (NASDAQ:DERM) Short Interest Up 31.3% in March

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totaling 3,456,540 shares, a growth...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Journey Medical (NASDAQ:DERM) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Journey Medical (NASDAQ:DERM - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.06) by...

HC Wainwright Forecasts Journey Medical Q1 Earnings

Journey Medical Corporation (NASDAQ:DERM - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Journey Medical in a research report issued to clients...

Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Journey Medical (DERM) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

HC Wainwright Reaffirms Buy Rating for Journey Medical (NASDAQ:DERM)

HC Wainwright restated a "buy" rating and set a $13.00 target price on shares of Journey Medical in a research report on Thursday...

Journey Medical Q4 Earnings Call Highlights

Journey Medical (NASDAQ:DERM) executives highlighted a milestone 2025 marked by the commercial launch of EMROSI, an internally developed oral treatment for the inflammatory lesions of rosacea, and...

Journey Medical (DERM) Expected to Announce Quarterly Earnings on Wednesday

Journey Medical (NASDAQ:DERM) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 25. (View Earnings Report at...

Journey Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by Brokerages

Journey Medical Corporation (NASDAQ:DERM - Get Free Report) has been given an average recommendation of "Hold" by the five ratings firms that are presently covering the stock, MarketBeat.com reports...

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Current Price	$5.39
Prev Close	$5.17
Open	$5.29
Dividend Yield	0.00%
50-Day Moving Average	$6.95
Beta	0.69
Avg. Volume	304,299.14
PE Ratio	-11.19

52-Week High	$9.56
52-Week Low	$4.31
Market Capitalization	$147.31M
EPS (Annual)	-$0.4666
Price to Book	4.59
Revenue Per Employee	$1.07M

DERM
Journey Medical Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DERM News

DERMJourney Medical Corp